355 related articles for article (PubMed ID: 15507091)
1. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
Elsner J; Escher SE; Forssmann U
Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
[TBL] [Abstract][Full Text] [Related]
2. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in CCR3 antagonists.
De Lucca GV
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):516-24. PubMed ID: 16889234
[TBL] [Abstract][Full Text] [Related]
4. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
[TBL] [Abstract][Full Text] [Related]
5. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of novel antagonists of the CCR3 receptor.
Warrior U; McKeegan EM; Rottinghaus SM; Garcia L; Traphagen L; Grayson G; Komater V; McNally T; Helfrich R; Harris RR; Bell RL; Burns DJ
J Biomol Screen; 2003 Jun; 8(3):324-31. PubMed ID: 12857386
[TBL] [Abstract][Full Text] [Related]
7. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
[TBL] [Abstract][Full Text] [Related]
8. Nasal mucosal immunoexpression of the mast cell chemoattractants TGF-beta, eotaxin, and stem cell factor and their receptors in allergic rhinitis.
Salib RJ; Kumar S; Wilson SJ; Howarth PH
J Allergy Clin Immunol; 2004 Oct; 114(4):799-806. PubMed ID: 15480318
[TBL] [Abstract][Full Text] [Related]
9. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
Sabroe I; Jorritsma A; Stubbs VE; Xanthou G; Jopling LA; Ponath PD; Williams TJ; Murphy PM; Pease JE
Eur J Immunol; 2005 Apr; 35(4):1301-10. PubMed ID: 15739168
[TBL] [Abstract][Full Text] [Related]
10. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
Duchesnes CE; Murphy PM; Williams TJ; Pease JE
Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
[TBL] [Abstract][Full Text] [Related]
11. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
Parody TR; Stone MJ
Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
[TBL] [Abstract][Full Text] [Related]
12. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.
Amerio P; Frezzolini A; Feliciani C; Verdolini R; Teofoli P; De Pità O; Puddu P
Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):81-94. PubMed ID: 14561178
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation.
Das AM; Vaddi KG; Solomon KA; Krauthauser C; Jiang X; McIntyre KW; Yang XX; Wadman E; Welch P; Covington M; Graden D; Yeleswaram K; Trzaskos JM; Newton RC; Mandlekar S; Ko SS; Carter PH; Davies P
J Pharmacol Exp Ther; 2006 Jul; 318(1):411-7. PubMed ID: 16614169
[TBL] [Abstract][Full Text] [Related]
14. Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4-stimulated epithelial cells.
Yuan Q; Campanella GS; Colvin RA; Hamilos DL; Jones KJ; Mathew A; Means TK; Luster AD
Eur J Immunol; 2006 Oct; 36(10):2700-14. PubMed ID: 16983721
[TBL] [Abstract][Full Text] [Related]
15. Small molecule antagonists for chemokine CCR3 receptors.
Willems LI; Ijzerman AP
Med Res Rev; 2010 Sep; 30(5):778-817. PubMed ID: 19967721
[TBL] [Abstract][Full Text] [Related]
16. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
Batt DG; Houghton GC; Roderick J; Santella JB; Wacker DA; Welch PK; Orlovsky YI; Wadman EA; Trzaskos JM; Davies P; Decicco CP; Carter PH
Bioorg Med Chem Lett; 2005 Feb; 15(3):787-91. PubMed ID: 15664858
[TBL] [Abstract][Full Text] [Related]
17. n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2.
Gupta S; Erdmann G; Schulz-Maronde S; Escher SE; Richter R; Forssmann WG; Elsner J; Forssmann U
Allergy; 2008 Oct; 63(10):1317-23. PubMed ID: 18782110
[TBL] [Abstract][Full Text] [Related]
18. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease.
Erin EM; Williams TJ; Barnes PJ; Hansel TT
Curr Drug Targets Inflamm Allergy; 2002 Jun; 1(2):201-14. PubMed ID: 14561201
[TBL] [Abstract][Full Text] [Related]
19. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.
El-Shazly A; Ishikawa T
Mediators Inflamm; 1999; 8(3):177-9. PubMed ID: 10704057
[TBL] [Abstract][Full Text] [Related]
20. Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists.
Bryan SA; Jose PJ; Topping JR; Wilhelm R; Soderberg C; Kertesz D; Barnes PJ; Williams TJ; Hansel TT; Sabroe I
Am J Respir Crit Care Med; 2002 Jun; 165(12):1602-9. PubMed ID: 12070060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
